Shopping Cart
- Remove All
- Your shopping cart is currently empty
JV-1-36, a growth hormone-releasing hormone (GHRH) antagonist, suppresses reactive oxygen species production in A549 lung cancer cells and serves as a research tool to investigate GHRH antagonists' effects in vitro [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | JV-1-36, a growth hormone-releasing hormone (GHRH) antagonist, suppresses reactive oxygen species production in A549 lung cancer cells and serves as a research tool to investigate GHRH antagonists' effects in vitro [1]. |
Cas No. | 221377-79-3 |
Sequence | {N-(2-phenylacetyl)}-Tyr-{d-Arg}-Asp-Ala-Ile-{4-Cl-Phe}-Thr-Asn-{Har}-{Tyr(Me)}-Arg-Lys-Val-Leu-{Abu}-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-{Nle}-{d-Arg}-{Har}-NH2 |
Sequence Short | {N-(2-phenylacetyl)}-Y-{d-Arg}-DAI-{4-Cl-Phe}-TN-{Har}-{Tyr(Me)}-RKVL-{Abu}-QLSARKLLQDI-{Nle}-{d-Arg}-{Har}-NH2 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.